Collegium Pharmaceutical, Inc.
COLL
$34.87
-$0.82-2.30%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.95M | 62.87M | 58.44M | 36.27M | 43.89M |
| Total Depreciation and Amortization | 225.45M | 226.07M | 226.19M | 211.43M | 190.29M |
| Total Amortization of Deferred Charges | 4.79M | 5.34M | 5.49M | 5.35M | 5.60M |
| Total Other Non-Cash Items | 30.24M | 31.28M | 14.06M | 19.14M | 23.72M |
| Change in Net Operating Assets | -4.39M | 3.76M | -13.26M | -68.71M | -65.07M |
| Cash from Operations | 331.04M | 329.32M | 290.92M | 203.48M | 198.44M |
| Capital Expenditure | -1.21M | -1.74M | -1.62M | -1.68M | -1.88M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | -267.54M | -267.54M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.01M | -61.79M | -53.60M | -4.11M | -9.89M |
| Cash from Investing | -52.23M | -63.53M | -55.23M | -273.32M | -279.31M |
| Total Debt Issued | 565.18M | 565.18M | 11.83M | 325.00M | 325.00M |
| Total Debt Repaid | -626.66M | -635.56M | -64.58M | -213.06M | -275.97M |
| Issuance of Common Stock | 4.93M | 5.64M | 4.83M | 3.16M | 8.57M |
| Repurchase of Common Stock | -42.79M | -37.95M | -62.39M | -61.57M | -76.91M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.00M | -7.56M | -19.38M | -19.38M | -12.38M |
| Cash from Financing | -106.35M | -110.25M | -129.70M | 34.15M | -31.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.46M | 155.55M | 105.99M | -35.69M | -112.56M |